© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Cefmenoxime Hydrochloride shows up regularly in pharmaceutical and scientific labs, known as a cephalosporin antibacterial agent. Its value comes from its broad-spectrum activity against both gram-positive and gram-negative bacteria. Health professionals rely on this material in the fight against diverse infections where other antibiotics might not hold up as well. Labs and factories track it using the HS Code 2941909099, supporting global trade and inventory management.
Walk into a lab, and you’ll most likely find Cefmenoxime Hydrochloride as a white to pale yellow crystalline powder or solid. Sometimes, users notice slightly different shapes, from coarse flakes to fine granular powder or even pearls, depending on manufacturer handling and storage methods. The powder form dissolves easily in water, producing clear, colorless solutions suited for injection or formulation work. In rare situations, you might come across larger crystal aggregates or compacted blocks, but most expect a consistent, manageable solid.
This compound, with a molecular formula of C16H17N9O5S3·HCl and a molar mass about 543.07 g/mol, presents a robust profile that stands up to scrutiny. Its chemical structure centers on the beta-lactam ring, typical of cephalosporins, combined with oxime side chains that boost resistance to beta-lactamases. This structural design gives the molecule both its antimicrobial power and stability in biological systems. The hydrochloride form, specifically, increases water solubility, making preparation for intravenous or intramuscular delivery efficient and predictable. Analytical testing reveals a melting point range between 160°C and 165°C (lit.), reflecting purity and proper synthesis.
High-purity Cefmenoxime Hydrochloride should appear as an odorless solid, lacking visible contaminants. The density falls in the range of 1.67 g/cm³ in its anhydrous state. Bulk shipments and laboratory stocks often require careful moisture control since the powder can absorb water from the air and start clumping or losing potency. Labs measure specific optical rotation and confirm crystalline character using X-ray diffraction or infrared spectroscopy, tools that establish quality benchmarks batch after batch. Solutions for research work usually come in concentrations between 10 mg/mL and 100 mg/mL, leveraging the compound’s steady solubility in sterile water or saline.
People working with Cefmenoxime Hydrochloride need to understand its safety profile. As with many antibiotics, accidental exposure can cause allergic reactions in sensitive individuals. Direct skin or eye contact causes irritation. Inhalation of dust or accidental ingestion brings its own risks, from respiratory symptoms to mild gastrointestinal upset. Handling guidelines suggest the use of gloves, safety glasses, and lab coats, with good ventilation to control airborne dust. Material Safety Data Sheets classify it as harmful if swallowed and potentially hazardous in bulk, though its primary danger sits with allergic sensitivity. Disposal, as with most pharmaceutical raw materials, requires incineration or chemical deactivation to prevent contamination of waste streams and water systems.
Pharmaceutical companies depend on high-grade precursors to synthesize Cefmenoxime Hydrochloride. The supply chain stretches from basic chemical providers to advanced synthesis labs. Raw materials must meet strict standards for purity—impurities lead to drug batches that fail potency or safety checks. The production process itself generates chemical byproducts, and factories must follow environmental rules to keep discharge and emissions within safe limits. Solvent recovery and waste treatment plants form crucial parts of any modern manufacturing line. Regulators look closely at each step due to the potential for environmental harm from improper disposal or leaks of antibiotic-laden wastewater.
My years in pharmaceutical supply chains have taught me that keeping Cefmenoxime Hydrochloride safe for staff and communities starts with rigorous training and robust safety culture. Routine audits help spot gaps in handling and waste management. Substituting less hazardous reagents in synthesis could reduce downstream risks. Developing closed-system transfer devices for hospital and pharmacy compounding helps minimize worker exposure. On the environmental front, advanced oxidation and filtration systems cut antimicrobial residues before they reach waterways. Regulators push for traceability from raw material to finished dose, and companies must get ahead with real-time monitoring and documented controls. A clear-eyed look at every step, backed up by tech and training, means suppliers deliver safe, quality product while protecting workers and the world outside the factory gates.
